John Sundy

Chief Tech/Sci/R&D Officer en PANDION THERAPEUTICS, INC. .

62 años

Consumer Services

Health Technology

Perfil

John Sundy is currently the Chief Medical Officer at Pandion Therapeutics, Inc. Prior to this, he was the Senior Vice President at Gilead Sciences, Inc. from 2014 to 2020.
Before that, he was an Associate Professor at Duke University and Duke-NUS Graduate Medical School Singapore from 2006 to 2014.
Dr. Sundy received his undergraduate degree from Bucknell University and his doctorate from Drexel University College of Medicine.

Cargos activos de John Sundy

Empresas	Cargo	Inicio
PANDION THERAPEUTICS, INC.	Chief Tech/Sci/R&D Officer	01/05/2020

Todos los cargos activos de John Sundy

Antiguos cargos conocidos de John Sundy.

Empresas	Cargo	Fin
GILEAD SCIENCES, INC.	Corporate Officer/Principal	01/04/2020
Duke University Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC.	Corporate Officer/Principal	01/01/2014
Duke-NUS Graduate Medical School Singapore	Corporate Officer/Principal	01/01/2014

Ver el detalle de la experiencia de John Sundy.

Formación de John Sundy.

Bucknell University	Undergraduate Degree
Drexel University College of Medicine	Doctorate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de John Sundy.

Relaciones

100 +

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	1
GILEAD SCIENCES, INC.	Health Technology

Empresas privadas	1
Pandion Therapeutics, Inc. Pandion Therapeutics, Inc. BiotechnologyHealth Technology Pandion Therapeutics, Inc. is a clinical stage biopharmaceutical company. It develops Therapeutic Autoimmune reguLatOry proteiN (TALON) drug design and discovery platform, which employ a modular approach to create a pipeline of product candidates using immunomodulatory effector modules that act at known control nodes within the immune network. The company was founded by Dr. Joanne Viney on September 19, 2016 and is headquartered in Watertown, MA.	Health Technology